comparemela.com
Home
Live Updates
Mycrodose Therapeutics Announces First Clinical Candidate fo
Mycrodose Therapeutics Announces First Clinical Candidate fo
Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis
San Diego, California--(Newsfile Corp. - March 31, 2022) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company specializing in the development of advanced drug delivery technologies
Related Keywords
California ,
United States ,
San Diego ,
Kostenloser Wertpapierhandel ,
Patrick Eckstrom ,
Christian Yavorsky ,
Frank Kochinke ,
Mycrodose Therapeutics Inc ,
California Newsfile Corp ,
World Health Organization ,
Microdosing Technology ,
Chief Research Officer ,
Chief Science Officer ,
Chad Conner ,
Chief Executive Officer ,
Protected Sustained Microdosing Technology ,
Mycrodose Therapeutics ,
Mycrodose ,
Herapeutics ,
Nnounces ,
First ,
Linical ,
Candidate ,
Ketamine ,
Ased ,
Drug ,
Delivery ,
Device ,
Mural ,
Mucositis ,